Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

0.897
Delayed Data
As of Dec 07
 -0.0271 / -2.94%
Today’s Change
0.64
Today|||52-Week Range
3.52
-66.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues28.9M20.4M4.5M44.5M
 
 
 
 
 
Cost of Goods Sold------287.0K
 
 
Depreciation And Amortization1.4M941.0K465.0K594.0K
 
 
 
 
 
 
Operating ExpensesGross Income------43.6M
 
 
General Expenses79.2M83.4M83.6M116.3M
 
 
 
 
 
Research And Development62.8M63.4M46.3M46.9M
 
 
 
 
 
Total Operating Expenses80.6M84.4M84.1M117.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-51.7M-64.0M-79.6M-72.7M
 
 
 
 
 
Extraordinary Charge0.00-5.8M0.000.00
 
 
Other Expenses57.0K88.0K732.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-51.5M-69.2M-78.0M-70.5M
 
 
 
 
 
Net Income-51.5M-69.2M-78.0M-70.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS88.4M94.4M126.3M160.5M
 
 
 
 
 
Shares To Calculate EPS Diluted88.4M94.4M126.3M160.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.58-$0.73-$0.62-$0.44
 
 
 
 
 
EPS Diluted-$0.58-$0.73-$0.62-$0.44